DRUG Bright Minds Biosciences Inc
- 1.370
- 0.0000.00%
Bright Minds Biosciences Inc News
Express News | Bright Minds Biosciences Brief: Announcing "Positive" QEEG (Quantitative Electroencephalogram) Data From Its First-in-Human Phase 1 Study of Lead Compound, BMB-101
Express News | Bright Minds Biosciences Brief: Announced "Positive" Topline Data for Its First-in-Human Phase 1 Study of Lead Compound, BMB-101
CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)
Toronto, Ontario--(Newsfile Corp. - Le 12 juillet/July 2023) - Bright Minds Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons
Bright Minds Announces Effective Date of Share Consolidation
Bright Minds Biosciences Brief: Says Received a "Favorable" Written Opinion From International Searching Authority for BMB-202
06:53 AM EDT, 04/19/2023 (MT Newswires) -- Bright Minds Biosciences Brief: Says Received a "Favorable" Written Opinion from International Searching Authority for BMB-202
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Decreases By 11.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 82
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Declines By 11.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Large Growth in Short Interest
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totallin
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Grows By 34.6%
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 478,500 shares,
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Decrease in Short Interest
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 471,600 share
AdvisorShares Investments LLC Boosts Stock Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)
AdvisorShares Investments LLC lifted its position in Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) by 115.5% during the 1st quarter, Holdings Channel.com reports. The institutional invest
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest Update
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the recipient of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 21
